Constantly changing your injection day prevents the medication from reaching a stable steady state in your system, which can make your appetite regulation less predictable and potentially increase side effects
Commenting on the findings, study author Edy Kornelius, MD, PhD, of Chung Shan Medical University in Taichung, Taiwan, said, Additional randomised, controlled trials that follow people over time are needed to confirm these findings, but these results are promising, since people with diabetes are at increased risk for developing epilepsy later in life. He added, Epilepsy can have many physical, psychological and social consequences, and many people do not respond to the current medications, so finding ways to reduce this risk is critical. The researchers emphasised that the study does not prove that GLP-1 drugs prevent epilepsy, but rather highlights a potential association that merits further investigation
Potential Interactions Take into account any current medical issues or prescription drugs you may be taking, since they may interact with L-carnitine
Heme on innate immunity and inflammation
Higher dose oral semaglutide (25 mg and 50 mg) has been studied in clinical trials and showed more substantial weight loss results, though these higher doses are not yet commercially available
Always monitor for new symptoms and consult your doctor
